Evolva Holding SA, a biosynthetic company, discovers and develops ingredients and processes for nutrition, health care, and wellness products in Switzerland and internationally. Its technologies are based on yeast that is used in the production of food and beverages. The company’s principal products include Resveratrol, a natural compound produced in grapes and other plants as a response against environmental stress factors; Stevia, a leafy green plant used as natural, zero-calorie, high-and intensity sweetener forms in beverages; Vanilla, a complex blend of flavour and fragrance compounds extracted from the seed pods of the vanilla orchid; Saffron, a spice for food coloring and flavoring, as well as for its aroma properties; and Pomecins that prevent mould and yeast growth. It also offers EV-077, a reversible antagonist of isoprostanes and prostanoids for diabetic complications; and EV-35, a bacterial type II topoisomerase inhibitor. Evolva Holding SA is based in Reinach, Switzerland.
evolva holding sa (EVE:SIX Swiss Ex)
Phone: 41 61 485 20 00
Fax: 41 61 485 20 01www.evolva.com
|No competitor information is available for EVE.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact EVOLVA HOLDING SA, please visit www.evolva.com. Company data is provided by Capital IQ. Please use this form to report any data issues.